SMAIO Adapts After NuVasive's Acquisition by Globus Medical, Shifts Focus to U.S. Market
- SMAIO ended its partnership with NuVasive following its acquisition by Globus Medical, allowing for a strategic refocus.
- The termination frees SMAIO from exclusivity constraints, enabling it to enhance visibility in the U.S. spinal surgery market.
- SMAIO aims to foster growth through new partnerships, Think Tanks, and educational programs in the spine industry.
SMAIO Shifts Focus Amid Termination of NuVasive Partnership
SMAIO, a Franco-American company specializing in complex spinal surgery, announces a strategic pivot following the termination of its co-development agreement with NuVasive. This partnership, initiated in Q1 2022, aimed to enhance SMAIO's surgical planning solutions in the U.S. and was marked by a significant $5 million investment from NuVasive during SMAIO's IPO in April 2022. The collaboration experienced a milestone moment in June 2023 when SMAIO received a $3 million payment after the FDA granted 510(k) clearance for co-developed software. However, the landscape shifted dramatically after NuVasive's acquisition by Globus Medical on September 1, 2023, leading both companies to mutually decide to end their co-development efforts.
The termination of this partnership carries immediate implications for SMAIO but does not hinder its sales, as no software products had progressed beyond internal development stages. By dissolving the licensing agreement, SMAIO can refocus its efforts without the constraints of exclusivity and sales restrictions previously tied to the partnership. Philippe Roussouly, the company's Chairman and CEO, underscores this transition as a pivotal moment in SMAIO's trajectory, as the company now aims to enhance its visibility and presence in the U.S. spinal surgery market.
To fuel growth, SMAIO is initiating proactive strategies, including forming Think Tanks, engaging with Key Opinion Leaders (KOLs), and launching training programs through a newly established North American scientific advisory board. These efforts aim to build a robust network and establish a strong foothold in the competitive U.S. market. Additionally, SMAIO is exploring potential new partnerships within the spine industry to further leverage its innovative Kheiron implant system. Roussouly expresses confidence in SMAIO's capabilities, emphasizing the company's dedication to maintaining momentum and capitalizing on emerging opportunities in the spinal surgery sector.
In related developments, SMAIO's commitment to innovation remains steadfast, as the company seeks to enhance its offerings despite recent changes. The focus on U.S. market expansion reflects a broader trend within the spine surgery industry, where companies are increasingly prioritizing advanced surgical technologies. SMAIO’s strategic initiatives signify its determination to navigate the evolving landscape effectively and ensure continued growth in a dynamic environment.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

